123 related articles for article (PubMed ID: 20127022)
1. Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue.
Dai H; Zhao S; Xu L; Chen A; Dai S
Oncol Rep; 2010 Mar; 23(3):795-9. PubMed ID: 20127022
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
3. [Expression of VEGF, bFGF and ER in endometrial carcinoma].
Bai X; Mi R
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):211-3. PubMed ID: 11783088
[TBL] [Abstract][Full Text] [Related]
4. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
5. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
Nakayama H; Sano T; Motegi A; Oyama T; Nakajima T
Pathol Int; 2005 Nov; 55(11):707-15. PubMed ID: 16271083
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
7. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
[TBL] [Abstract][Full Text] [Related]
9. Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients.
Gao D; Zhao ZZ; Liang XH; Li Y; Cao Y; Liu ZS
Nephrology (Carlton); 2011 Nov; 16(8):736-42. PubMed ID: 21771176
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
Wang H; Chen G; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
[TBL] [Abstract][Full Text] [Related]
11. [Expression of pituitary tumor-transforming gene in endometrial carcinoma].
Wang YK; Cui N; Li J; Luo B
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):538-42. PubMed ID: 15363353
[TBL] [Abstract][Full Text] [Related]
12. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic peptide vascular endothelial growth factor-basic fibroblast growth factor signaling is up-regulated in a rat pressure ulcer model.
Yang JJ; Wang XL; Shi BW; Huang F
Anat Rec (Hoboken); 2013 Aug; 296(8):1161-8. PubMed ID: 23740668
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma.
Dobrzycka B; Mackowiak-Matejczyk B; Kinalski M; Terlikowski SJ
Gynecol Oncol; 2013 Mar; 128(3):454-60. PubMed ID: 23206584
[TBL] [Abstract][Full Text] [Related]
15. Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue.
Pan XY; Wang B; Che YC; Weng ZP; Dai HY; Peng W
Int J Gynecol Cancer; 2007; 17(1):233-41. PubMed ID: 17291259
[TBL] [Abstract][Full Text] [Related]
16. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
17. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Cancer Lett; 1998 Dec; 134(1):15-22. PubMed ID: 10381125
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tgfb1 protein in endometrioid adenocarcinoma.
Soufla G; Sifakis S; Porichis F; Spandidos DA
Eur J Clin Invest; 2013 Jan; 43(1):79-90. PubMed ID: 23176363
[TBL] [Abstract][Full Text] [Related]
20. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
